Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Globus Medical, Inc. $GMED

Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in shares of Globus Medical, Inc. (NYSE:GMED) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 15,237 shares of the medical device company’s stock, valued at approximately $1,330,000.

Several other institutional investors also recently bought and sold shares of the company. Legato Capital Management LLC increased its holdings in Globus Medical by 2.6% during the 4th quarter. Legato Capital Management LLC now owns 23,228 shares of the medical device company’s stock worth $2,028,000 after purchasing an additional 595 shares during the period. Meiji Yasuda Asset Management Co Ltd. purchased a new position in Globus Medical during the 4th quarter worth $223,000. Global Retirement Partners LLC increased its holdings in shares of Globus Medical by 692.8% in the 4th quarter. Global Retirement Partners LLC now owns 5,058 shares of the medical device company’s stock valued at $442,000 after acquiring an additional 4,420 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Globus Medical by 31.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 11,679 shares of the medical device company’s stock valued at $1,020,000 after acquiring an additional 2,771 shares during the period. Finally, Larson Financial Group LLC increased its holdings in shares of Globus Medical by 83.4% in the 4th quarter. Larson Financial Group LLC now owns 532 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 242 shares during the period. 95.16% of the stock is currently owned by hedge funds and other institutional investors.

Globus Medical Price Performance

Globus Medical stock opened at $84.84 on Friday. The stock has a market capitalization of $11.52 billion, a price-to-earnings ratio of 19.73, a PEG ratio of 1.75 and a beta of 1.00. Globus Medical, Inc. has a 1-year low of $51.79 and a 1-year high of $101.40. The business has a fifty day moving average price of $87.26 and a 200-day moving average price of $87.80.

Globus Medical (NYSE:GMED) last posted its quarterly earnings data on Thursday, May 7th. The medical device company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. The firm had revenue of $759.85 million during the quarter, compared to analysts’ expectations of $740.35 million. Globus Medical had a return on equity of 13.46% and a net margin of 18.92%.The business’s quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.68 EPS. Globus Medical has set its FY 2026 guidance at 4.700-4.800 EPS. On average, equities research analysts anticipate that Globus Medical, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Truist Financial set a $115.00 price target on Globus Medical in a report on Wednesday, February 25th. TD Cowen upgraded Globus Medical to a “strong-buy” rating in a report on Tuesday, January 27th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Globus Medical in a report on Wednesday, April 15th. Wells Fargo & Company cut their price target on Globus Medical from $104.00 to $103.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Finally, Barclays lifted their price target on Globus Medical from $118.00 to $123.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Globus Medical currently has an average rating of “Moderate Buy” and a consensus price target of $106.36.

Insider Buying and Selling at Globus Medical

In other news, EVP Kelly Huller sold 20,000 shares of the firm’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $94.50, for a total value of $1,890,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 18.38% of the stock is owned by insiders.

About Globus Medical

Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.